monoclonal antibodies against nt probnp (HyTest)
HyTest is a verified supplier 
HyTest manufactures this product 
96
Structured Review
HyTest
monoclonal antibodies against nt probnp
Monoclonal Antibodies Against Nt Probnp, supplied by HyTest, used in various techniques. Bioz Stars score: 96/100, based on 77 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+nt+probnp/NT-proBNP/pm41576580-67-0-4
Average 96 stars, based on 77 article reviews
Monoclonal Antibodies Against Nt Probnp, supplied by HyTest, used in various techniques. Bioz Stars score: 96/100, based on 77 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+nt+probnp/NT-proBNP/pm41576580-67-0-4
Average 96 stars, based on 77 article reviews
monoclonal antibodies against nt probnp - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Concentration Assay:Article Title: Metal-Organic Framework@Gold Nanoparticles Enables Point-of-Care Diagnostics To Have Comparable Analytical Performance to Chemiluminescent Immunoassays. Article Snippet: Lateral flow immunoassay (LFIA) is a vital pointof-care testing (POCT) technique that is widely used for on-site detection and in vitro diagnosis.. Many diseases, particularly cardiovascular diseases (CVDs), require the quantitative detection of multiple biomarkers across a broad dynamic range.. Recurrent viral infections like COVID-19 elevate CVDs risk, necessitating early warning and prognostic monitoring, especially based on POCT of multiple blood biomarkers of D-dimer, NT-proBNP, and cTnI across a broad range from pg/mL to μg/mL. Multiplex Assay:Article Title: Metal-Organic Framework@Gold Nanoparticles Enables Point-of-Care Diagnostics To Have Comparable Analytical Performance to Chemiluminescent Immunoassays. Article Snippet: Lateral flow immunoassay (LFIA) is a vital pointof-care testing (POCT) technique that is widely used for on-site detection and in vitro diagnosis.. Many diseases, particularly cardiovascular diseases (CVDs), require the quantitative detection of multiple biomarkers across a broad dynamic range.. Recurrent viral infections like COVID-19 elevate CVDs risk, necessitating early warning and prognostic monitoring, especially based on POCT of multiple blood biomarkers of D-dimer, NT-proBNP, and cTnI across a broad range from pg/mL to μg/mL. Enzyme-linked Immunosorbent Assay:Article Title: Metal-Organic Framework@Gold Nanoparticles Enables Point-of-Care Diagnostics To Have Comparable Analytical Performance to Chemiluminescent Immunoassays. Article Snippet: Lateral flow immunoassay (LFIA) is a vital pointof-care testing (POCT) technique that is widely used for on-site detection and in vitro diagnosis.. Many diseases, particularly cardiovascular diseases (CVDs), require the quantitative detection of multiple biomarkers across a broad dynamic range.. Recurrent viral infections like COVID-19 elevate CVDs risk, necessitating early warning and prognostic monitoring, especially based on POCT of multiple blood biomarkers of D-dimer, NT-proBNP, and cTnI across a broad range from pg/mL to μg/mL. Two Tailed Test:Article Title: Metal-Organic Framework@Gold Nanoparticles Enables Point-of-Care Diagnostics To Have Comparable Analytical Performance to Chemiluminescent Immunoassays. Article Snippet: Lateral flow immunoassay (LFIA) is a vital pointof-care testing (POCT) technique that is widely used for on-site detection and in vitro diagnosis.. Many diseases, particularly cardiovascular diseases (CVDs), require the quantitative detection of multiple biomarkers across a broad dynamic range.. Recurrent viral infections like COVID-19 elevate CVDs risk, necessitating early warning and prognostic monitoring, especially based on POCT of multiple blood biomarkers of D-dimer, NT-proBNP, and cTnI across a broad range from pg/mL to μg/mL. |